GlassScriptPhysician profile
Amanda Curtis
NPI 1790065977
$6,299.20
in general payments reported to CMS, 2019-2025
47 companies · $1,329 in 2025
The $1,329 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,582 · 2022: $930 · 2023: $881 · 2024: $1,577 · 2025: $1,329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,787.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $878.79 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $716.96 | 2021-2025 | Farxiga, Breztri, Tezspire |
| Abbvie INC. | $618.92 | 2021-2025 | |
| Glaxosmithkline, LLC. | $377.44 | 2021-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Pfizer INC. | $334.09 | 2021-2025 | |
| Novo Nordisk INC | $321.14 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Abbott Laboratories | $314.77 | 2021-2025 | Freestyle Libre 3, Freestyle Libre |
| Boehringer Ingelheim Pharmaceuticals, INC. | $308.84 | 2021-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $176.60 | 2021-2025 | |
| Exact Sciences Corporation | $156.38 | 2023-2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $149.61 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $141.05 | 2021-2025 | Rexulti, Jynarque |
| Merck Sharp & Dohme LLC | $130.22 | 2021-2023 | Verquvo, Steglatro, Dificid |
| Amgen INC. | $127.76 | 2021-2024 | Repatha, Otezla |
| Janssen Scientific Affairs, LLC | $125.00 | 2021 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Curtis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.